Copyright Reports & Markets. All rights reserved.

Global Pre-Implantation Genetic Diagnosis (PGD) Market Status and Forecast 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Status and Forecast (2016-2027)
      • 1.3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Pre-Implantation Genetic Diagnosis (PGD) Supply by Company

    • 2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Value by Company
    • 2.2 Pre-Implantation Genetic Diagnosis (PGD) Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Pre-Implantation Genetic Diagnosis (PGD) Market Status by Type

    • 3.1 Pre-Implantation Genetic Diagnosis (PGD) Type Introduction
      • 3.1.1 Chromosomal Abnormalities
      • 3.1.2 X-linked Diseases
      • 3.1.3 Freeze Embryo Testing
      • 3.1.4 Aneuploidy Screening
      • 3.1.5 HLA
      • 3.1.6 Others
    • 3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Pre-Implantation Genetic Diagnosis (PGD) Market Status by Application

    • 4.1 Pre-Implantation Genetic Diagnosis (PGD) Segment by Application
      • 4.1.1 Stem Cell Therapy
      • 4.1.2 IVF Prognosis
      • 4.1.3 Late-Onset Genetic Disorders
      • 4.1.4 Inherited Genetic Disease
      • 4.1.5 Others
    • 4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Pre-Implantation Genetic Diagnosis (PGD) Market Status by Region

    • 5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market by Region
    • 5.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Status
    • 5.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Status
    • 5.4 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Status
    • 5.5 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Status
    • 5.6 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Status

    6 North America Pre-Implantation Genetic Diagnosis (PGD) Market Status

    • 6.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Status

    • 7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Status

    • 8.1 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Status

    • 9.1 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Status

    • 10.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Type and by Application

    • 12.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Value Forecast (2022-2027)
    • 12.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Type
    • 12.3 Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Application

    13 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Region/Country

    • 13.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Thermo Fisher Scientific Inc.
      • 14.1.1 Company Information
      • 14.1.2 Pre-Implantation Genetic Diagnosis (PGD) Product Introduction
      • 14.1.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Roche
      • 14.2.1 Company Information
      • 14.2.2 Pre-Implantation Genetic Diagnosis (PGD) Product Introduction
      • 14.2.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Reproductive Genetic Innovations
      • 14.3.1 Company Information
      • 14.3.2 Pre-Implantation Genetic Diagnosis (PGD) Product Introduction
      • 14.3.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Quest Diagnostics
      • 14.4.1 Company Information
      • 14.4.2 Pre-Implantation Genetic Diagnosis (PGD) Product Introduction
      • 14.4.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Natera, Inc.
      • 14.5.1 Company Information
      • 14.5.2 Pre-Implantation Genetic Diagnosis (PGD) Product Introduction
      • 14.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 LabCorp
      • 14.6.1 Company Information
      • 14.6.2 Pre-Implantation Genetic Diagnosis (PGD) Product Introduction
      • 14.6.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Illumina, Inc.
      • 14.7.1 Company Information
      • 14.7.2 Pre-Implantation Genetic Diagnosis (PGD) Product Introduction
      • 14.7.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 IGENOMIX
      • 14.8.1 Company Information
      • 14.8.2 Pre-Implantation Genetic Diagnosis (PGD) Product Introduction
      • 14.8.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Genea Limited
      • 14.9.1 Company Information
      • 14.9.2 Pre-Implantation Genetic Diagnosis (PGD) Product Introduction
      • 14.9.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Cooper Medical, Inc.
      • 14.10.1 Company Information
      • 14.10.2 Pre-Implantation Genetic Diagnosis (PGD) Product Introduction
      • 14.10.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 CombiMatrix
    • 14.12 California Pacific Medical Center (CPMC)

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Pre-Implantation Genetic Diagnosis (PGD) market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Pre-Implantation Genetic Diagnosis (PGD) industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Pre-Implantation Genetic Diagnosis (PGD) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Pre-Implantation Genetic Diagnosis (PGD) Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Pre-Implantation Genetic Diagnosis (PGD) market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Pre-Implantation Genetic Diagnosis (PGD) Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Pre-Implantation Genetic Diagnosis (PGD) industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Chromosomal Abnormalities
      X-linked Diseases
      Freeze Embryo Testing
      Aneuploidy Screening
      HLA
      Others

      Segmented by Application
      Stem Cell Therapy
      IVF Prognosis
      Late-Onset Genetic Disorders
      Inherited Genetic Disease
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Thermo Fisher Scientific Inc.
      Roche
      Reproductive Genetic Innovations
      Quest Diagnostics
      Natera, Inc.
      LabCorp
      Illumina, Inc.
      IGENOMIX
      Genea Limited
      Cooper Medical, Inc.
      CombiMatrix
      California Pacific Medical Center (CPMC)
      Buy now